881674-27-7

Basic information

• Product Name: 1H-Pyrrole-3-carboxylic acid, 5-cyclohexyl-, ethyl ester
• CAS NO: 881674-27-7
• Molecular Formula: C13H19NO2
• Molecular Weight: 221.299
• Mol File: 881674-27-7.mol

Chemical Properties

• CAS DataBase Reference: 1H-Pyrrole-3-carboxylic acid, 5-cyclohexyl-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrrole-3-carboxylic acid, 5-cyclohexyl-, ethyl ester(881674-27-7)
• EPA Substance Registry System: 1H-Pyrrole-3-carboxylic acid, 5-cyclohexyl-, ethyl ester(881674-27-7)

Safety Data

• Hazardous Substances Data: 881674-27-7(Hazardous Substances Data)

Usage

Molecular weight

229.31 g/mol

Structure

A five-membered aromatic ring with one nitrogen atom, a carboxyl group (-COOH) attached to position 3, a cyclohexyl group attached to position 5, and an ethyl ester group (-OCH2CH3) attached to the carboxyl group.

Appearance

Pale yellow solid

Solubility

Insoluble in water, soluble in organic solvents such as ethanol, methanol, and acetone.

Melting point

94-98°C

Boiling point

Not readily available due to its stability as a solid at high temperatures.

Reactivity

Reacts with other chemicals to form various derivatives and can be used as an intermediate in the synthesis of pharmaceutical compounds and agrochemicals.

Uses

Commonly used as an intermediate in the synthesis of pharmaceutical compounds and agrochemicals, with potential applications in the fields of medicine and agriculture due to its ability to modulate biological activities.

Unique properties

The presence of the cyclohexyl group provides the compound with unique chemical and physical properties that make it suitable for diverse applications in the chemical industry.

Upstream product

• 108-85-0 1-bromocyclohexane 
• 2703-17-5 methyl 1H-pyrrole-3-carboxylate 
• 37964-17-3 pyrrole-3-carboxylic acid ethyl ester 
• 7446-70-0 aluminum (III) chloride 

Downstream Products

• 881675-47-4 ethyl 5-cyclohexyl-1-(phenylsulfonyl)-1H-pyrrole-3-carboxylate 

Relevant articles and documents

Proton pump inhibitors

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R 1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R 2 , R 3 and R 4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R 5 and R 6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.

PROTON PUMP INHIBITORS

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R2, R3 and R4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R5 and R6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.

PROTON PUMP INHIBITORS

Proton pump inhibitors which have excellent proton pumping activity and which can be converted in vivo into proton pump inhibitors to exhibit antiulcer effect and so on, containing compounds represented by the general formula (I) or salts thereof or prodrugs of the same: (I) wherein X and Y are each independently a free valency or a spacer whose main chain has 1 to 20 carbon atoms; R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; R2, R3 and R4 are each independently hydrogen, an optionally substituted hydrocarbon group, optionally substituted thienyl, optionally substituted benzo[b]thienyl, optionally substituted furyl, optionally substituted pyridyl, optionally substituted pyrazolyl, optionally substituted pyrimidinyl, acyl, halogeno, cyano, or nitro; and R5 and R6 are each independently hydrogen or an optionally substituted hydrocarbon group.